As per MRFR analysis, the South America Structural Heart Devices Market Size was estimated at 49.7 (USD Million) in 2024.The South America Structural Heart Devices Market Industry is expected to grow from 53.9(USD Million) in 2025 to 118.54 (USD Million) by 2035. The South America Structural Heart Devices Market CAGR (growth rate) is expected to be around 7.428% during the forecast period (2025 - 2035).
In South America, the Structural Heart Devices Market is being influenced by several important trends. prevalence of structural heart diseases across the region is a major market driver. This is particularly noteworthy given that countries like Brazil and Argentina have noted an increase in the aging population, leading to a heightened risk of heart disease. The healthcare systems are increasingly focusing on innovative and effective treatment options, paving the way for advancements in structural heart devices.
Opportunities to be explored in this market include investments in research and development aimed at creating minimally invasive procedures, which can improve patient recovery times and overall outcomes.As awareness about heart health increases among the population, there is an opportunity for companies to expand their product offerings in line with patient needs. Furthermore, improving healthcare infrastructure in South American countries indicates a potential for better access to these advanced medical devices. Trends in recent times show a rise in partnerships between local healthcare providers and international device manufacturers to improve technology transfer and skill development.
This is significant as it not only enhances the quality of care but also increases the local production of structural heart devices, facilitating better availability and affordability.Regulatory changes in South America are also emerging, promoting faster approvals for new medical technologies, which can create an environment conducive to innovation in the structural heart devices segment. Overall, the market is transitioning with a focus on patient-centric approaches and technological advancements.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The South America Structural Heart Devices Market Industry is experiencing growth driven largely by the rising prevalence of cardiovascular diseases. According to the Pan American Health Organization, cardiovascular diseases account for 31% of total deaths in South America, which translates to approximately 1.3 million deaths annually. This alarming statistic highlights the urgent need for advanced medical devices, including structural heart devices like transcatheter aortic valve replacements and left atrial appendage occluders, which are critical for improving patient outcomes.
Moreover, established organizations such as the Brazilian Society of Cardiology have been advocating for increased healthcare investments focusing on heart disease management. As the healthcare infrastructure continues to advance in South America and access to such technologies improves, it is likely to drive demand for structural heart devices significantly, supporting market growth in the coming years.
Ongoing technological advancements in minimally invasive surgical techniques and device innovations are propelling the South America Structural Heart Devices Market Industry. For instance, advancements in 3D imaging technologies have enhanced the precision of structural heart procedures. According to industry reports, the integration of advanced imaging in cardiovascular interventions has led to reduced procedure times by up to 30%. Notable players such as Medtronic and Abbott Laboratories are introducing innovative structural heart devices that improve procedural success rates and patient safety.Brazil's Health Regulatory Agency has recently improved the device approval process, and this will further encourage innovation. The “sync” between advanced technology and regulations is expected to improve growth in the market.
Government initiatives aimed at improving heart health in South America are also serving as crucial drivers for the South America Structural Heart Devices Market Industry. Various health ministries across South American countries, including initiatives by the Argentine Ministry of Health, have launched campaigns to increase awareness and interventions for heart diseases.
These campaigns often include funding allocations for purchasing advanced health technologies.For instance, in 2020, a significant increase of 12% was observed in healthcare budgets focused on cardiovascular health across several South American countries, promoting the adoption of innovative devices. Such proactive government involvement not only enhances access to these life-saving devices but also encourages local manufacturers to invest in research and development, further driving market expansion.
The South America Structural Heart Devices Market showcases a diverse landscape under the Type segment, encompassing critical components like Heart Valve Devices, Annuloplasty Rings, Occluders, and Delivery Systems, which play essential roles in treating structural heart diseases. Heart Valve Devices hold a significant place in this market, as they are crucial in addressing various valvular heart conditions, thereby enhancing patient outcomes and quality of life. With a growing elderly population in South America, the demand for effective heart valve interventions is particularly pressing.
Annuloplasty Rings, vital for mitral and tricuspid valve repair procedures, also experience considerable usage as surgeons increasingly opt for these devices to enhance procedural success rates and minimize complications. Occluders, utilized to treat conditions like atrial septal defects, have gained traction due to their minimally invasive nature, which aligns with the ongoing trend of reducing recovery times and hospital stays. Delivery Systems facilitate the implantation of these devices with precision, representing a critical area of innovation in the market.
Each type, while distinct in its application, collectively contributes to the South America Structural Heart Devices Market growth narrative by addressing the rising incidence of heart diseases driven by lifestyle shifts and an aging population. The market is also influenced by ongoing advancements in medical technology, improving device efficacy and safety, thus providing robust opportunities for further expansion. As healthcare systems in countries like Brazil, Argentina, and Chile enhance their focus on cardiovascular health, the structural heart devices market will significantly benefit, making the Type segment an integral part of the overall industry dynamics.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The South America Structural Heart Devices Market is intricately segmented by indications, primarily focusing on Valvular Heart Disease and Cardiomyopathy. Valvular Heart Disease remains a significant concern in the region, driven by an increasing prevalence of rheumatic heart diseases, particularly in countries like Brazil and Argentina, where access to healthcare plays a critical role in timely diagnosis and treatment.
Cardiomyopathy is also gaining attention due to its association with genetic factors and lifestyle changes affecting the population.Both indications present substantial opportunities for growth within the South America Structural Heart Devices Market as healthcare providers aim to enhance patient outcomes through advanced therapeutic options. Furthermore, the evolving landscape of cardiovascular treatment, coupled with increasing awareness and technological innovations, supports the expansion of these segments, highlighting their importance in improving cardiovascular health in South America. As both conditions demand specialized devices and interventions, they play a pivotal role in shaping the overall industry landscape while addressing significant unmet medical needs and fostering market growth.
The Procedure segment of the South America Structural Heart Devices Market is characterized by a significant focus on both Replacement Procedures and Repair Procedures, which play crucial roles in the management of structural heart conditions. Replacement Procedures typically involve the implantation of innovative devices to replace damaged heart valves, significantly improving patient outcomes and quality of life.
On the other hand, Repair Procedures emphasize minimally invasive techniques aimed at correcting structural abnormalities without full valve replacement, which appeals to a wider range of patients due to reduced recovery times.This segment is driven by an increasing prevalence of heart diseases and an aging population within South America, necessitating advanced surgical interventions. Moreover, technological advancements are enhancing the efficacy and safety of these procedures, leading to a growing adoption of such treatments by healthcare professionals.
The South America Structural Heart Devices Market data indicates that cities with advanced healthcare infrastructure, like So Paulo and Buenos Aires, serve as key hubs for these procedures, reflecting their importance in the regional healthcare landscape.As awareness of heart health continues to rise, the market is poised for further growth as patients increasingly seek out these life-saving interventions.
The South America Structural Heart Devices Market demonstrates considerable potential across its Regional segment, with key countries like Brazil, Mexico, Argentina, and the Rest of South America significantly contributing to overall market dynamics. Brazil holds a majority holding within this sector, reflecting its advanced healthcare infrastructure and rising prevalence of cardiovascular diseases, driving demand for innovative structural heart solutions.
Mexico, known for its developing medical device industry, is increasingly adopting advanced technologies, resulting in a robust growth trajectory in this market.Argentina is also establishing itself with a growing healthcare focus, making it a noteworthy player in structural heart device adoption. Additionally, the Rest of South America encompasses various nations that present emerging opportunities driven by increasing awareness about cardiac health and the adoption of novel medical therapies. Collectively, these regions signify an evolving landscape in the South America Structural Heart Devices Market, influenced by greater healthcare access and improving technological advancements, setting the stage for sustained market growth in the coming years.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The South America Structural Heart Devices Market is characterized by a dynamic competitive landscape shaped by a growing demand for advanced cardiovascular treatments. With the rising prevalence of heart diseases in the region, the market is seeing intensified competition among various players striving to capture a larger share. The market is marked by rapid technological advancements, collaborations, and strategic partnerships as companies leverage innovations to enhance their product offerings.
Additionally, government initiatives aimed at improving healthcare infrastructure and increasing funding for medical research further contribute to the competitive intensity within the structural heart devices sector. This environment presents both challenges and opportunities for companies, prompting them to adopt diverse strategies to maintain a competitive edge.Medtronic has established a strong foothold in the South America Structural Heart Devices Market with a comprehensive portfolio that caters to a wide range of cardiovascular conditions.
The company’s strengths lie in its extensive research and development capabilities, which are focused on delivering state-of-the-art devices such as transcatheter heart valves and ventricular assist devices. Medtronic has made significant investments in localizing its production facilities and establishing robust distribution networks across South America.
Additionally, its strong brand recognition and lasting relationships with healthcare professionals enable the company to effectively promote its solutions. Medtronic's commitment to quality and patient safety has further solidified its position as a leader in the market, allowing it to respond swiftly to emerging trends and customer needs in the region.Terumo is another key player in the South America Structural Heart Devices Market, known for its commitment to innovation and quality in healthcare solutions.
The company focuses on developing a range of cardiovascular devices, including vascular grafts and catheters specifically designed for complex heart procedures. Terumo's strategic partnerships and collaborations with local healthcare institutions enhance its market presence, allowing it to stay ahead of the competition. The company also emphasizes training and educational initiatives for healthcare providers, which not only promotes the effective use of its devices but also builds trust within the medical community. Recent mergers and acquisitions have bolstered Terumo’s positioning in the market, enabling the company to expand its product offerings and increase its operational capabilities in South America, thereby enhancing its competitive strength in a rapidly evolving landscape.
Recent developments in the South America Structural Heart Devices Market have shown significant activity, with key players such as Medtronic, Abbott Laboratories, and Boston Scientific making strides in product innovation and market expansion. The demand for structural heart devices is on the rise due to the increasing prevalence of cardiovascular diseases in the region, with countries like Brazil and Argentina seeing notable growth in healthcare expenditure. In March 2023, Medtronic announced the launch of their latest transcatheter aortic valve technology in Brazil, aiming to improve treatment outcomes for patients with aortic stenosis.
Simultaneously, Abbott Laboratories has bolstered its market position by enhancing its supply chain for cardiac devices across South America, driving broader access to patients. As for mergers and acquisitions, in February 2023, Neovasc completed a strategic partnership with a local distributor in Brazil to expand their renal denervation systems. Additionally, in January 2022, Boston Scientific acquired a leading local startup specializing in minimally invasive heart valve technologies, further solidifying its presence in the region. This surge in activities is reflective of a growing market propelled by increasing healthcare investment and an aging population across South America.
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 49.7(USD Million) |
| MARKET SIZE 2024 | 53.9(USD Million) |
| MARKET SIZE 2035 | 118.54(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.428% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Medtronic, Terumo, AtriCure, Abbott Laboratories, Corvia Medical, Neovasc, B. Braun Melsungen, Boston Scientific, CardiaTec, Ramsay Santé, LivaNova, AngioDynamics, CryoLife, JenaValve Technology, Edwards Lifesciences |
| SEGMENTS COVERED | Type, Indication, Procedure, Regional |
| KEY MARKET OPPORTUNITIES | Aging population increasing heart disorders, Advancements in minimally invasive procedures, Rising demand for innovative treatments, Expanding healthcare infrastructure investments, Growing awareness of cardiovascular health |
| KEY MARKET DYNAMICS | rising cardiovascular disease prevalence, increasing geriatric population, advancements in minimally invasive techniques, growing healthcare investment, regulatory support for innovations |
| COUNTRIES COVERED | Brazil, Mexico, Argentina, Rest of South America |
Frequently Asked Questions (FAQ) :
The South America Structural Heart Devices Market is expected to be valued at 53.9 million USD in 2024.
The market is projected to reach a value of 118.54 million USD by 2035.
The expected CAGR for the market from 2025 to 2035 is 7.428%.
Brazil is expected to hold the largest market share, valued at 18.0 million USD in 2024.
The market in Argentina is valued at 10.0 million USD in 2024.
Key players include Medtronic, Abbott Laboratories, and Boston Scientific among others.
Heart Valve Devices are expected to be valued at 44.0 million USD by 2035.
Occluders are valued at 15.0 million USD in 2024 and expected to reach 33.0 million USD by 2035.
The market presents opportunities driven by increasing cardiovascular disease prevalence and technological advancements.
Mexico's market is valued at 12.0 million USD in 2024 and is projected to grow to 26.0 million USD by 2035.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
